Tremfya indct 200MG/2ML X2 pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJH9V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,417
Award facts
- Contract value 100% obligated
- $21,416.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $21,416.77, awards AmerisourceBergen Drug Corp the supply of Tremfya (guselkumab) 200mg/2mL injectable pens for the Defense Logistics Agency. The contract was competitively awarded with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 16, 2026. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the parent company Cencora, Inc.'s (doing business as AmerisourceBergen) substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Tremfya is an immunosuppressant medication indicated for the treatment of plaque psoriasis and psoriatic arthritis, representing one of many specialty pharmaceutical products delivered through AmerisourceBergen's federal contract portfolio. The Defense Logistics Agency utilizes such delivery orders to maintain adequate pharmaceutical inventory across military treatment facilities and veterans' healthcare systems. AmerisourceBergen's demonstrated capability to fulfill both high-volume and specialized medical supply requirements through competitive federal contracting underscores its critical role in the defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FJH9V?
SPE2DR26FJH9V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FJH9V worth?
The government has obligated $21,417 on SPE2DR26FJH9V.
Is contract SPE2DR26FJH9V an order under another contract?
Yes. SPE2DR26FJH9V is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH9V competed?
The extent of competition for SPE2DR26FJH9V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award